<< Genta announces private placement of Convertible Notes for $25M | Butler Health System to implement Alpha Systems' enterprise EDM solution >>

NOVAVAX' Stage B 2009 H1N1 VLP pandemic influenza vaccine study in Mexico: Enrollment complete

Published on March 8, 2010 at 9:24 AM · No Comments

Novavax, Inc. (Nasdaq: NVAX) announced today that the enrollment of over 3,500 subjects in Mexico has been completed in Stage B of its pivotal 2009 H1N1 virus-like-particle (VLP) pandemic influenza vaccine study. With the 1,000 subjects already enrolled in Stage A of the trial, the enrollment in this pivotal trial is now complete with over 4,500 subjects.

Continued on Next page >>

Scientists discover two HIV variants in cerebrospinal fluid of HAD patientsWhen the virus that causes AIDS infects the central nervous system, it can lead to the development o...
Advaxis submits protocol revision for ADXS-HPV CIN Phase II studyAdvaxis, Inc., a leader in developing the next generation of immunotherapies for cancer and infectio...
Alexion joins EURORDIS, NORD and medical communities to observe Rare Disease Day 2011Alexion Pharmaceuticals, Inc. joins the European Organization for Rare Diseases, the National Organi...
Sangamo completes enrollment in SB-509-901 Phase 2b clinical trial in diabetic neuropathySangamo BioSciences, Inc. announced today that the company completed enrollment of its Phase 2b doub...
Discovery Labs reports preliminary results from Surfaxin Phase 2 trial in children with Acute Respiratory FailureDiscovery Laboratories, Inc., reports preliminary results from its Phase 2 clinical trial of Surfaxi...
U.S. businesses are unprepared to deal with flu pandemicConflicting guidance on the depth and breadth of the H1N1 virus - the upcoming revisit of swine flu ...
Another bird flu death in IndonesiaBird flu has claimed another victim in Indonesia bringing the country's death toll from the deadly v...
Clinical trial of gefitinib for advanced lung cancer closes earlyResearchers have closed a randomized clinical trial comparing gefitinib (Iressa) vs. placebo followi...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.